Amarin Corporation (AMRN) Reaches Agreement WIth FDA For Phase 3 Trial of AMR101

May 6, 2009 9:36 AM EDT Send to a Friend
Amarin Corporation plc (NASDAQ: AMRN) announced that it has reached agreement with the FDA under a Special Protocol Assessment (SPA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login